DOCSLIB.ORG

Excel Guidelines FINAL(1).Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Excel Guidelines FINAL(1).Pdf Fungal Group Fungal disease Source Guidelines Relevant articles British Society for Medical Mycology best practice recommendations for the General BSMM diagnosis of serious fungal diseases Invasive (Diagnosis) 2015 Candida diseases ESCMID Diagnostic procedures 2012 Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the General BSMM British Society for Medical Mycology 2013 CPIC Clinical Pharmacogenetics ESCMID guideline for the diagnosis and ESCMID management of Candida diseases 2012: 1. Developing European guidelines in clinical microbiology and infectious diseases 2. Non-neutropenic adult patients 3. Prevention and management of invasive infections in neonates and Candida diseases children caused by Candida spp 4. Adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT) Consensus guidelines for the treatment of yeast infections in the haematology, RACP oncology, and intensive care setting 2014 IDSA IDSA clinical practice guidelines 2016 Recommendations on invasive candidiasis in patients with complicated EPICO intra-abdominal infection and surgical patients with ICU extended stay Candidaemia and invasive Brazilian guidelines for the candidiasis management of candidiasis – a joint meeting report of three medical BJID societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical Recommendations for the management LAIMN of candidemia in children in Latin America ISPD guidelines/recommendations ISPD 2011 Candida peritonitis Special article: reducing the risks of peritoneal dialysis-related infections IDSA IDSA clinical practice guidelines 2010 WHO WHO management guidelines 2011 Guidelines for the prevention and treatment of opportunistic infections in AIDSinfo HIV-infected Adults and adolescents 2015 Cryptococcal meningitis Invasive (Treatment) Cryptococcal meningitis Guideline for the prevention, diagnosis Southern African and management of cryptococcal HIV clinicians meningitis among HIV-infection society persons: 2013 update Consensus guidelines for the treatment of yeast infections in the haematology, RACP oncology, and intensive care setting 2014 IDSA IDSA Clinical practice guidelines 2007 Guidelines for the prevention and Histoplasmosis disseminated Invasive (Treatment) treatment of opportunistic infections in AIDSinfo HIV-infected Adults and adolescents 2013 IDSA Clinical practice guidelines 2007 IDSA Histoplasmosis acute pulmonary Guidelines for the prevention and treatment of opportunistic infections in HIV-infected Adults and adolescents AIDSinfo 2013 IDSA IDSA Clinical practice guidelines 2016 Invasive aspergillosis Treatment of invasive fungal infections AGIHO in cancer patients—2014 update ERS/EAACI guidelines for acute and chronic rhinosinusitis with and without ERS/EAACI Invasive rhinosinusitis nasal polyps based on systematic review 2012 ESCMID and ECMM joint clinical guidelines for the diagnosis ESCMID andmanagement of mucormycosis 2013 Mucormycosis Diagnosis and treatment of mucormycosis in patients with hematological ECIL malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3) WHO guidelines for management of opportunistic infections and WHO antiretroviral treatment in adolescents and adults in ethopia 2008 Guidelines for the prevention and treatment of opportunistic infections in AIDSinfo HIV-infected Adults and adolescents 2015 Article: An official American Thoracic Society statement: Pneumocystis pneumonia ATS Treatment of fungal infections in adult pulmonary and critical care patients. Consensus guidelines for the treatment of yeast infections in the haematology, RACP oncology, and intensive care setting 2014 ECIL guidelines for treatment of ECIL Pneumocystis jirovecii pneumonia in non- HIV-infected haematology patients Invasive (Treatment) Pneumocystis pneumonia Talaromyces(Penicillium) marneffei infection ESCMID and ECMM joint clinical guidelines for the diagnosis and Rare invasive yeast infections ESCMID/ECMM management of rare invasive yeast infections ESCMID and ECMM joint guidelines on diagnosis and management of Hyalohphyomycosis ESCMID/ECMM hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others International ERS/ATS guidelines on ERS/ATS definition, evaluation and treatment of severe asthma 2014 ABPA Article: Allergic bronchopulmonary aspergillosis: review of IDSA IDSA Clinical practice guidelines 2016 literature and proposal of new diagnostic and Allergic classification criteria Allergic fungal rhinosinusitis Occupational Lung Disease (Fungal) International ERS/ATS guidelines on SAFS ERS/ATS definition, evaluation and treatment of severe asthma 2014 Thunderstorm Asthma CPA guidelines in European ESCMID/ERS Respiratory Journal 2015 Chronic pulmonary aspergillosis (CPA) IDSA IDSA Clinical practice guidelines 2016 IDSA IDSA clinical practice guidelines 2008 Blastomycosis IDSA Coccidioidomycosis guidelines IDSA 2016 Coccidioidomycosis Guidelines for the prevention and treatment of opportunistic infections in AIDSinfo HIV-infected Adults and adolescents 2013 Managing corneal Fungal keratitis disease: focus on Chronic Lung or Deep suppurative keratitis tissue Fungus ball of the sinus IDSA IDSA Clinical practice guidelines 2008 Granulomatous invasive fungal rhinosinusitis Histoplasmosis chronic cavitary IDSA IDSA clinical practice guidelines 2007 pulmonary Article: practice guidelines for the treatment of coccidioidomycosis Paracoccidioidomycosis Article: Treatment options for paracoccididodomycosis and new strategies investigated Article: Executive summary of Japanese Deep-seated Mycosis domestic guidelines for management of deep- seasted Mycosis 2014 2013 European guideline Candida balanitis for the management of balanoposthitis IDSA IDSA clinical practice guidelines 2016 Guidelines for Prevention and Oesophageal candidiasis Treatment of Opportunisitic infections in AIDSinfo HIV-infected Adults and adolescents 2015 IDSA IDSA clinical practice guidelines 2016 Mucosal infection Guidelines on the treatment of skin and WHO oral HIV-associated conditions in children and adults 2014 Oral candidiasis Guidelines for Prevention and Treatment of Opportunisitic infections in AIDSinfo HIV-infected Adults and adolescents 2015 ESCMID Patients with HIV infection or AIDS Candida diseases Guideline: vulvovaginal candidosis (AWMF 015/072) (excluding chronic Vaginal thrush (yeast infection) mucocutaneous candidosis) 2015 Athlete's foot ESCMID and ECMM joint clinical guidelines for the diagnosis and ESCMID management of systemic Chromoblastomycosis phaeohyphomycosis: diseases caused by black fungi 2014 British Association of Dermatologists’ BAD guidelines for the management of Onychomycosis onychomycosis 2014 Clinical Practice Guidelines: Acute AAO-HNSF Otitis externa Otitis Externa 2014 Guidelines of care for superficial AAD mycotic infections of the skin: Pityriasis Pityriasis versicolor (tinea) versicolor1996 Ringworm (Tinea corporis) Evidence-based Danish Guidelines for DSD the treatment of Malassezia related skin Seborrheic dermatitis diseases 2015 Clinical practice guidelines for the IDSA management of sporotrichosis 2007 Sporotrichosis update British Association of Dermatologists' BAD guidelines for the management of tinea capitis 2014 Skin, nails and hair Guidelines on the treatment of skin and Tinea capitis WHO oral HIV-associated conditions in children and adults 2014 Guidelines for the management of tinea ESPD capitis in children 2010 Guidelines on the treatment of skin and WHO oral HIV-associated conditions in children and adults 2014 Tinea cruris Skin, nails and hair Guidelines of care for Tinea cruris superficial mycotic infections of the skin: AAD Tinea corporis, tinea cruris, tinea faciei, tinea manuum and tinea pedis Guidelines on the treatment of skin and WHO oral HIV-associated conditions in children and adults 2014 Guidelines of care for Tinea manuum superficial mycotic infections of the skin: AAD Tinea corporis, tinea cruris, tinea faciei, tinea manuum and tinea pedis.
Load more

Recommended publications
  • Tinea Faciei Presenting Butterfly Erythema in a Boy
    TINEA FACIEI PRESENTING BUTTERFLY ERYTHEMA IN A BOY Serpil Şener Department of Dermatology, Beydagi State Hospital, Malatya, Turkey Tinea faciei is the most frequently misdiagnosed entity among cutaneous fungal infections. The atypical clinical features support the separation of this disease from tinea corporis. This often lacks a distinct raised scaly border, and may mimic a photodermatosis such as lupus erythematosus or dermatomyositis. Other photodermatoses to consider include polymorphous light eruption, contact dermatitis, and rosacea. In this article, a 9-year-old boy with tinea faciei presenting butterfly rash was reported because of its rarity. Key words: Dermatophytosis, tinea faciei, butterfly rash Eur J Gen Med 2007; 4(3):141-142 INTRODUCTION DISCUSSION Tinea faciei is a superficial dermatophyte Tinea faciei is a relatively uncommon infection limited to the glabrous skin of the superficial dermatophyte infection limited to face. In pediatric and female patients, the the glabrous skin of the face. It can be found infection may appear on any surface of the worldwide, but has a predilection for tropical face. In men, the condition is known as tinea humid climates (4). The causative agent varies barbae when a dermatophyte infection of according to the geographic region. In Asia, bearded areas occurs (1). The clinical features Trychophyton mentagrophytes and T. rubrum vary considerable. Annular or circinate are the most frequent etiologic agents (1,5). lesions, plaques with a raised margin, simple Infection results either from direct contact to papular lesions, and flat patches of erythema, an external source, for example a domestic as well as scaling, itching and exacerbation animal, or there may be secondary spread after sun exposure may occur (1-3).
    [Show full text]
  • Therapies for Common Cutaneous Fungal Infections
    MedicineToday 2014; 15(6): 35-47 PEER REVIEWED FEATURE 2 CPD POINTS Therapies for common cutaneous fungal infections KENG-EE THAI MB BS(Hons), BMedSci(Hons), FACD Key points A practical approach to the diagnosis and treatment of common fungal • Fungal infection should infections of the skin and hair is provided. Topical antifungal therapies always be in the differential are effective and usually used as first-line therapy, with oral antifungals diagnosis of any scaly rash. being saved for recalcitrant infections. Treatment should be for several • Topical antifungal agents are typically adequate treatment weeks at least. for simple tinea. • Oral antifungal therapy may inea and yeast infections are among the dermatophytoses (tinea) and yeast infections be required for extensive most common diagnoses found in general and their differential diagnoses and treatments disease, fungal folliculitis and practice and dermatology. Although are then discussed (Table). tinea involving the face, hair- antifungal therapies are effective in these bearing areas, palms and T infections, an accurate diagnosis is required to ANTIFUNGAL THERAPIES soles. avoid misuse of these or other topical agents. Topical antifungal preparations are the most • Tinea should be suspected if Furthermore, subsequent active prevention is commonly prescribed agents for dermatomy- there is unilateral hand just as important as the initial treatment of the coses, with systemic agents being used for dermatitis and rash on both fungal infection. complex, widespread tinea or when topical agents feet – ‘one hand and two feet’ This article provides a practical approach fail for tinea or yeast infections. The pharmacol- involvement. to antifungal therapy for common fungal infec- ogy of the systemic agents is discussed first here.
    [Show full text]
  • Tinea Faciei Presenting Butterfly Erythema in a Boy
    TINEA FACIEI PRESENTING BUTTERFLY ERYTHEMA IN A BOY Serpil Şener Department of Dermatology, Beydagi State Hospital, Malatya, Turkey Tinea faciei is the most frequently misdiagnosed entity among cutaneous fungal infections. The atypical clinical features support the separation of this disease from tinea corporis. This often lacks a distinct raised scaly border, and may mimic a photodermatosis such as lupus erythematosus or dermatomyositis. Other photodermatoses to consider include polymorphous light eruption, contact dermatitis, and rosacea. In this article, a 9-year-old boy with tinea faciei presenting butterfly rash was reported because of its rarity. Key words: Dermatophytosis, tinea faciei, butterfly rash Eur J Gen Med 2007; 4(3):141-142 INTRODUCTION DISCUSSION Tinea faciei is a superficial dermatophyte Tinea faciei is a relatively uncommon infection limited to the glabrous skin of the superficial dermatophyte infection limited to face. In pediatric and female patients, the the glabrous skin of the face. It can be found infection may appear on any surface of the worldwide, but has a predilection for tropical face. In men, the condition is known as tinea humid climates (4). The causative agent varies barbae when a dermatophyte infection of according to the geographic region. In Asia, bearded areas occurs (1). The clinical features Trychophyton mentagrophytes and T. rubrum vary considerable. Annular or circinate are the most frequent etiologic agents (1,5). lesions, plaques with a raised margin, simple Infection results either from direct contact to papular lesions, and flat patches of erythema, an external source, for example a domestic as well as scaling, itching and exacerbation animal, or there may be secondary spread after sun exposure may occur (1-3).
    [Show full text]
  • Therapies for Common Cutaneous Fungal Infections
    MedicineToday 2014; 15(6): 35-47 PEER REVIEWED FEATURE 2 CPD POINTS Therapies for common cutaneous fungal infections KENG-EE THAI MB BS(Hons), BMedSci(Hons), FACD Key points A practical approach to the diagnosis and treatment of common fungal • Fungal infection should infections of the skin and hair is provided. Topical antifungal therapies always be in the differential are effective and usually used as first-line therapy, with oral antifungals diagnosis of any scaly rash. being saved for recalcitrant infections. Treatment should be for several • Topical antifungal agents are typically adequate treatment weeks at least. for simple tinea. • Oral antifungal therapy may inea and yeast infections are among the dermatophytoses (tinea) and yeast infections be required for extensive most common diagnoses found in general and their differential diagnoses and treatments disease, fungal folliculitis and practice and dermatology. Although are then discussed (Table). tinea involving the face, hair- antifungal therapies are effective in these bearing areas, palms and T infections, an accurate diagnosis is required to ANTIFUNGAL THERAPIES soles. avoid misuse of these or other topical agents. Topical antifungal preparations are the most • Tinea should be suspected if Furthermore, subsequent active prevention is commonly prescribed agents for dermatomy- there is unilateral hand just as important as the initial treatment of the coses, with systemic agents being used for dermatitis and rash on both fungal infection. complex, widespread tinea or when topical agents feet – ‘one hand and two feet’ This article provides a practical approach fail for tinea or yeast infections. The pharmacol- involvement. to antifungal therapy for common fungal infec- ogy of the systemic agents is discussed first here.
    [Show full text]
  • Fungal Infections (Mycoses): Dermatophytoses (Tinea, Ringworm)
    Editorial | Journal of Gandaki Medical College-Nepal Fungal Infections (Mycoses): Dermatophytoses (Tinea, Ringworm) Reddy KR Professor & Head Microbiology Department Gandaki Medical College & Teaching Hospital, Pokhara, Nepal Medical Mycology, a study of fungal epidemiology, ecology, pathogenesis, diagnosis, prevention and treatment in human beings, is a newly recognized discipline of biomedical sciences, advancing rapidly. Earlier, the fungi were believed to be mere contaminants, commensals or nonpathogenic agents but now these are commonly recognized as medically relevant organisms causing potentially fatal diseases. The discipline of medical mycology attained recognition as an independent medical speciality in the world sciences in 1910 when French dermatologist Journal of Raymond Jacques Adrien Sabouraud (1864 - 1936) published his seminal treatise Les Teignes. This monumental work was a comprehensive account of most of then GANDAKI known dermatophytes, which is still being referred by the mycologists. Thus he MEDICAL referred as the “Father of Medical Mycology”. COLLEGE- has laid down the foundation of the field of Medical Mycology. He has been aptly There are significant developments in treatment modalities of fungal infections NEPAL antifungal agent available. Nystatin was discovered in 1951 and subsequently and we have achieved new prospects. However, till 1950s there was no specific (J-GMC-N) amphotericin B was introduced in 1957 and was sanctioned for treatment of human beings. In the 1970s, the field was dominated by the azole derivatives. J-GMC-N | Volume 10 | Issue 01 developed to treat fungal infections. By the end of the 20th century, the fungi have Now this is the most active field of interest, where potential drugs are being January-June 2017 been reported to be developing drug resistance, especially among yeasts.
    [Show full text]
  • Tinea Faciei in a Mother and Daughter Caused by Arthroderma Benhamiae
    Brief Report https://doi.org/10.5021/ad.2018.30.2.241 Tinea Faciei in a Mother and Daughter Caused by Arthroderma benhamiae Weon Ju Lee, Dong Hyuk Eun, Yong Hyun Jang, Seok-Jong Lee, Yong Jun Bang1, Jae Bok Jun1 Department of Dermatology, Kyungpook National University School of Medicine, 1Institute of Medical Mycology, Catholic Skin Clinic, Daegu, Korea Dear Editor: fungal culture on potato-corn meal-Tween 80 agar showed Two patients presented with peripherally spreading, an- white, granular, and downy colonies with a radiating pe- nular, inflammatory patches on the face for several months. riphery and raised center (Fig. 1). The long mycelium had The patients were a 46-year-old woman and her 8-year-old numerous small, round microconidia and several macro- daughter. Both had contact with a rabbit with inflam- conidia or spiral hyphae on lactophenol cotton blue stain matory skin lesions, but they had no other specific past (Fig. 2). REBA and gene sequencing using gapped BLAST medical or family history. They were diagnosed with der- and position-specific iterated-BLAST programs identified A. matophytosis caused by Arthroderma benhamiae using benhamiae. The program revealed 99% or 100% homology KOH examination, fungal culture, lactophenol cotton blue with accession number Z98016, JX413540, JX122298, stain, reverse blot hybridization assay (REBA) and DNA JX122297, AB458188, AB458165, AB458176, AB458143, gene sequencing. KOH examination results were positive AB458145, JN134088, KC253946, AB686489, AB686487, in both patients. Resembling Trichophyton interdigitale, AB686486, AB686485, AB686484, AB686483, AB686482, Fig. 1. (A) Peripherally radiating and centrally raised, granular and downy colonies cultured from mother and (B) her daughter.
    [Show full text]
  • Fungal Group Fungal Disease Source Guidelines
    Fungal Fungal disease Source Guidelines Relevant articles Group ESCMID guideline for the diagnosis and management of Candida diseases 2012: 1. Developing European guidelines in clinical microbiology and infectious diseases 2. Diagnostic procedures 3. Non-neutropenic adult patients 4. Prevention and management of Candida diseases ESCMID invasive infections in neonates and children caused by Candida spp 5. Adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT) 6. Patients with HIV infection or AIDS Candidaemia and IDSA clinical practice guidelines 2016 IDSA invasive candidiasis ISPD ISPD guidelines/recommendations Candida peritonitis Special article: reducing the risks of peritoneal dialysis-related infections Invasive IDSA IDSA clinical practice guidelines 2010 WHO management guidelines WHO Cryptococcal meningitis Guidelines for the prevention and AIDSinfo treatment of opportunistic infections in HIV-infected Adults and adolescents Southern Guideline for the prevention, African diagnosis and management of HIV cryptococcal meningitis among HIV- clinicians infection persons: 2013 update society IDSA Clinical practice guidelines 2007 IDSA Histoplasmosis disseminated Guidelines for the prevention and treatment of opportunistic infections in AIDSinfo HIV-infected Adults and adolescents IDSA Clinical practice guidelines 2007 Histoplasmosis IDSA acute pulmonary AIDSinfo Guidelines for the prevention and treatment of opportunistic infections in HIV-infected Adults and adolescents Invasive IDSA Clinical
    [Show full text]
  • Fungal Group Fungal Disease Source Guidelines Relevant Articles
    Fungal Fungal disease Source Guidelines Relevant articles Group ESCMID guideline for the diagnosis and management of Candida diseases 2012: 1. Developing European guidelines in clinical microbiology and infectious diseases 2. Diagnostic procedures 3. Non-neutropenic adult patients 4. Prevention and management of Candida diseases ESCMID invasive infections in neonates and children caused by Candida spp 5. Adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT) 6. Patients with HIV infection or AIDS Candidaemia and IDSA clinical practice guidelines 2016 IDSA invasive candidiasis ISPD ISPD guidelines/recommendations Candida peritonitis Peritoneal Dialysis international article Invasive IDSA clinical practice guidelines 2010 IDSA WHO WHO management guidelines Guidelines for the prevention and Cryptococcal treatment of opportunistic infections in AIDSinfo meningitis HIV-infected Adults and adolescents Southern Guideline for the prevention, African diagnosis and management of HIV cryptococcal meningitis among HIV- clinicians infection persons: 2013 update society IDSA IDSA Clinical practice guidelines 2007 Histoplasmosis Guidelines for the prevention and treatment of opportunistic infections in disseminated AIDSinfo HIV-infected Adults and adolescents IDSA IDSA Clinical practice guidelines 2007 Histoplasmosis Guidelines for the prevention and treatment of opportunistic infections in acute pulmonary AIDSinfo HIV-infected Adults and adolescents Invasive IDSA IDSA Clinical practice guidelines 2008 aspergillosis
    [Show full text]
  • Common Fungal Infections 13
    Chapter 13 13 Common Fungal Infections With respect to the mode of presentation and propa- 13.1.1 gation in tissue there are three categories of fungi: Clinical Appearance 1. Yeast fungi (unicellular fungi) exist only as spores Different parts of the body may be affected. With re- and produce new spores by budding. spect to the location, the eruption may have a more or 2. Filamentous fungi produce filaments (hyphae), but less characteristic appearance. This is the reason why not yeast cells. Some kinds of filamentous fungi the disease is named after the part of the body affected: form septate hyphae (i.e., the hyphae consist of a tinea corporis (includes trunk and limbs), tinea faciei, chain of cells separated by septa); other kinds pro- tinea cruris, tinea manuum, tinea pedis, tinea capitis, duce non-septate hyphae. Filamentous fungi may tinea barbae, and tinea unguium. brake up into spores called arthrospores. A con- For example, tinea circinata is the characteristic glomeration of hyphae is called mycelium. lesion usually seen in tinea corporis. It presents as a 3. Dimorphic fungi are able to form both hyphae and rounded, erythematous, slightly infiltrated, more or yeast spores. They produce new yeast cells by bud- less scaling plaque, which extends gradually at the pe- ding from spores as well as from hyphae. riphery and becomes circinate or annular due to cen- The most common kinds of fungal skin infections are tral healing. The active border is clearly defined and dermatophytosis, Malassezia furfur/pityrosporum in- slightly raised and may contain pustules. fections, candidiasis, and aspergillosis.
    [Show full text]
  • Fungal Infections
    Fungal infections Natural defence against fungi y Fatty acid content of the skin y pH of the skin, mucosal surfaces and body fluids y Epidermal turnover y Normal flora Predisposing factors y Tropical climate y Manual labour population y Low socioeconomic status y Profuse sweating y Friction with clothes, synthetic innerwear y Malnourishment y Immunosuppressed patients HIV, Congenital Immunodeficiencies, patients on corticosteroids, immunosuppressive drugs, Diabetes Fungal infections: Classification y Superficial cutaneous: y Surface infections eg. P.versicolor, Dermatophytosis, Candidiasis, T.nigra, Piedra y Subcutaneous: Mycetoma, Chromoblastomycosis, Sporotrichosis y Systemic: (opportunistic infection) Histoplasmosis, Candidiasis Of these categories, Dermatophytosis, P.versicolor, Candidiasis are common in daily practice Pityriasis versicolor y Etiologic agent: Malassezia furfur Clinical features: y Common among youth y Genetic predisposition, familial occurrence y Multiple, discrete, discoloured, macules. y Fawn, brown, grey or hypopigmented y Pinhead sized to large sheets of discolouration y Seborrheic areas, upper half of body: trunk, arms, neck, abdomen. y Scratch sign positive PITYRIASIS VERSICOLOR P.versicolor : Investigations y Wood’s Lamp examination: y Yellow fluorescence y KOH preparation: Spaghetti and meatball appearance Coarse mycelium, fragmented to short filaments 2-5 micron wide and up to 2-5 micron long, together with spherical, thick-walled yeasts 2-8 micron in diameter, arranged in grape like fashion. P.versicolor: Differential diagnosis y Vitiligo y Pityriasis rosea y Secondary syphilis y Seborrhoeic dermatitis y Erythrasma y Melasma Treatment P. versicolor Topical: y Ketoconazole , Clotrimazole, Miconazole, Bifonazole, Oxiconazole, Butenafine,Terbinafine, Selenium sulfide, Sodium thiosulphate Oral: y Fluconazole 400mg single dose y Ketoconazole 200mg OD x 14days yGriseofulvin is NOT effective.
    [Show full text]
  • Neglected Fungal Zoonoses: Hidden Threats to Man and Animals
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector REVIEW Neglected fungal zoonoses: hidden threats to man and animals S. Seyedmousavi1,2,3, J. Guillot4, A. Tolooe5, P. E. Verweij2 and G. S. de Hoog6,7,8,9,10 1) Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, 2) Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands, 3) Invasive Fungi Research Center, Mazandaran University of Medical Sciences, Sari, Iran, 4) Department of Parasitology- Mycology, Dynamyic Research Group, EnvA, UPEC, UPE, École Nationale Vétérinaire d’Alfort, Maisons-Alfort, France, 5) Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran, 6) CBS-KNAW Fungal Biodiversity Centre, Utrecht, 7) Institute for Biodiversity and Ecosystem Dynamics, University of Amsterdam, Amsterdam, The Netherlands, 8) Peking University Health Science Center, Research Center for Medical Mycology, Beijing, 9) Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China and 10) King Abdullaziz University, Jeddah, Saudi Arabia Abstract Zoonotic fungi can be naturally transmitted between animals and humans, and in some cases cause significant public health problems. A number of mycoses associated with zoonotic transmission are among the group of the most common fungal diseases, worldwide. It is, however, notable that some fungal diseases with zoonotic potential have lacked adequate attention in international public health efforts, leading to insufficient attention on their preventive strategies. This review aims to highlight some mycoses whose zoonotic potential received less attention, including infections caused by Talaromyces (Penicillium) marneffei, Lacazia loboi, Emmonsia spp., Basidiobolus ranarum, Conidiobolus spp.
    [Show full text]
  • Diagnosis of Dermatophytoses Still Problematic for General Practitioners
    Forum Dermatologicum 2017, tom 3, nr 4, 157–165 Copyright © 2017 Via Medica PRACA KAZUISTYCZNA ISSN 2451–1501 Diagnosis of dermatophytoses still problematic for general practitioners — 10 case studies and review of literature Nicole Machnikowski1, Wioletta Barańska-Rybak2, Aleksandra Wilkowska2, Roman Nowicki2 1Ninewells Hospital & Medical School, Dundee, United Kingdom 2Department of Dermatology, Venerology and Allergology, University Clinical Centre in Gdansk, Gdansk, Poland ABSTRACT Dermatophytoses, also referred to as tinea or ringworm, is a fungal infection of keratinized tissues (skin, hair, nails) caused by Trichophyton, Microsporum and Epidermophyton dermatophytes. It presents clinically as an erythematous, scaly, pruritic rash with a well-defined border. Diagnostic errors are not uncommon with this condition. It can have a close resemblance to lesions of another etiology (e.g. psoriasis, discoid eczema) or present atypically due to the prior use of topical steroid preparations (e.g. tinea incognito). A cohort of 10 cases with varying initial misdiagnoses of dermatophyte infection were analysed based on on their cutaneous presentations, clinical course, and treatments in order to give guidance for general practitioners. Forum Derm. 2017; 3, 4: 157–165 Key words: tinea, dermatophyte, corticosteroids, antifungal treatment, tinea incognito INTRODUCTION the most common fungi responsible and accounted for as Dermatophytoses, also referred to as tinea or ringworm, much as 89.1% of fungal infections [9, 10]. This was followed is a fungal infection of keratinized tissues (skin, hair, nails) by Candida (8.4%) and Malassezia (2.4%) infections. Among caused by Trichophyton, Microsporum and Epidermophyton dermatophytoses, tinea pedis is the most frequent, then in dermatophytes. It presents clinically as an erythematous, decreasing order, tinea unguium, tinea corporis, tinea cruris, scaly, pruritic rash with a well-defined border [1, 2].
    [Show full text]